Xtl Biopharmaceuticals Ltd Net Income per Employee (XTLB), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Xtl Biopharmaceuticals Ltd   (NASDAQ: XTLB)
 

Xtl Biopharmaceuticals Ltd Net Income per Employee

XTLB's Quarterly Results, Trends, Rankings, Statistics

The Healthcare sector has seen employees of 132 other companies achieving higher income per employee. While Xtl Biopharmaceuticals Ltd 's total ranking has deteriorated compared to the previous quarter from to 4005.


What is Income per Employee Ratio?






XTLB Net Income per Employee (Dec 31 2023)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ - - - -57,000 -57,000
XTLB's Total Ranking # 4005 # # # 1 # 4275
Seq. Net Income Change - - - - -


XTLB Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 133
Healthcare Sector # 426
Overall Market # 4005

Net Income per Employee Statistics
High Average Low
$ 726,000 $ -67,567 $ -590,800
(Dec 31 2018)   (Dec 31 2020)







Companies with similar Income per Employee for 12 month ending Dec 31 2023, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2023Number of Employees Dec 31 2023


Date modified: 2024-05-02T15:34:24+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.